Search

Vertex Touts Positive Triple-Drug Data For Cystic Fibrosis Patients

VERTEX TOUTS POSITIVE TRIPLE-DRUG DATA FOR CYSTIC FIBROSIS PATIENTS

Vertex Pharmaceuticals continued its march away from being the biggest loser in the hepatitis C wars and toward increasing dominance...

 
 
 
Vertex Bags Concert's Rival CF Drug For $160M, Plans Combo Studies

VERTEX BAGS CONCERT'S RIVAL CF DRUG FOR $160M, PLANS COMBO STUDIES

Concert Pharmaceuticals has been plugging away with an experimental cystic fibrosis drug that, if successful, might someday pose a...